We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGPI icon
976
MGP Ingredients
MGPI
$383M
$468K ﹤0.01%
11,786
-28,759
-71% -$1.07M
MEOH icon
977
Methanex
MEOH
$4.24B
$467K ﹤0.01%
19,159
-110,310
-85% -$2.34M
MREO
978
Mereo BioPharma
MREO
$56M
$467K ﹤0.01%
178,310
-88,870
-33% -$260K
GIS icon
979
General Mills
GIS
$20.1B
$463K ﹤0.01%
+7,500
New +$469K
CEVA icon
980
CEVA Inc
CEVA
$850M
$460K ﹤0.01%
+11,680
New +$463K
DOYU
981
DouYu International Holdings
DOYU
$142M
$460K ﹤0.01%
3,486
-76,892
-96% -$11M
CVX icon
982
Chevron
CVX
$385B
$457K ﹤0.01%
+6,350
New +$534K
QS icon
983
QuantumScape Corp
QS
$3.84B
$454K ﹤0.01%
+27,079
New +$401K
GMS
984
DELISTED
GMS Inc
GMS
$452K ﹤0.01%
18,750
-38,744
-67% -$949K
ONT
985
Onterris Inc
ONT
$572M
$451K ﹤0.01%
+18,943
New +$481K
EME icon
986
Emcor
EME
$36B
$450K ﹤0.01%
+6,635
New +$460K
TRP icon
987
TC Energy
TRP
$66.7B
$449K ﹤0.01%
10,730
-80,418
-88% -$3.68M
CSTL icon
988
Castle Biosciences
CSTL
$997M
$445K ﹤0.01%
8,650
-52,238
-86% -$2.32M
CHDN icon
989
Churchill Downs
CHDN
$6.2B
$439K ﹤0.01%
+5,364
New +$416K
AY
990
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$438K ﹤0.01%
+15,333
New +$448K
HHR
991
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$438K ﹤0.01%
+17,885
New +$380K
ANNX icon
992
Annexon
ANNX
$873M
$437K ﹤0.01%
+14,447
New +$339K
ZG icon
993
Zillow
ZG
$7.73B
$434K ﹤0.01%
+4,269
New +$332K
ARGO
994
DELISTED
Argo Group International Holdings, Ltd.
ARGO
$433K ﹤0.01%
12,575
-11,737
-48% -$410K
WT icon
995
WisdomTree
WT
$3.37B
$432K ﹤0.01%
135,198
-127,490
-49% -$460K
NSP icon
996
Insperity
NSP
$1.96B
$431K ﹤0.01%
+6,573
New +$438K
SPTN
997
DELISTED
SpartanNash
SPTN
$431K ﹤0.01%
+26,414
New +$527K
RILY icon
998
BRC Group Holdings
RILY
$293M
$430K ﹤0.01%
+17,169
New +$432K
HOG icon
999
Harley-Davidson
HOG
$2.8B
$427K ﹤0.01%
17,379
-120,145
-87% -$3.24M
CBT icon
1000
Cabot Corp
CBT
$4.52B
$422K ﹤0.01%
+11,704
New +$445K

Similar funds

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.